Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1387662 | PMC |
| http://dx.doi.org/10.1097/00000658-196911000-00015 | DOI Listing |
Publication Analysis
Top Keywords
fibrinogen-transmitted hepatitis
4
hepatitis surgical
4
surgical patient
4
fibrinogen-transmitted
1
surgical
1
patient
1
Similar Publications
Risk of authoritarianism: fibrinogen-transmitted hepatitis C in Japan.
Lancet
December 2007
Department of Planning, Information and Management, University of Tokyo Hospital, Tokyo, Japan.
In 1977, the US Food and Drug Administration revoked all licences for fibrinogen concentrate because of the risk for hepatitis infection and suspected lack of effectiveness. However, in Japan, fibrinogen concentrate was used routinely for treatment of obstetric bleeding until 1988. Even in 1997, academic texts by Japanese authorities in obstetrics still recommended that obstetricians use the product.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!